Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2020

Quarterly Financial Data [Abstract]

Schedule of Quarterly Financial Data

	2020 Quarters
(in millions, except per share data)	1st		2nd		3rd		4th
Net revenues	$	6,359	$	6,367	$	7,123	$	6,304
Gross profit	$	2,873	$	3,287	$	3,717	$	3,146
Net earnings (losses)	$	1,550	$	1,938	$	(956)	$	1,922
Net earnings (losses) attributable to Altria	$	1,552	$	1,943	$	(952)	$	1,924
Per share data:
Basic and diluted earnings (losses) per share attributable to Altria	$	0.83	$	1.04	$	(0.51)	$	1.03
	2019 Quarters
(in millions, except per share data)	1st		2nd		3rd		4th
Net revenues	$	5,628	$	6,619	$	6,856	$	6,007
Gross profit	$	2,811	$	3,319	$	3,497	$	3,084
Net earnings (losses)	$	1,121	$	1,997	$	(2,602)	$	(1,814)
Net earnings (losses) attributable to Altria	$	1,120	$	1,996	$	(2,600)	$	(1,809)
Per share data:
Basic earnings (losses) per share attributable to Altria	$	0.60	$	1.07	$	(1.39)	$	(0.97)
Diluted earnings (losses) per share attributable to Altria	$	0.60	$	1.07	$	(1.39)	$	(1.00)

Schedule Of Pre-Tax Charges (Gains) Included In Net Earnings

During 2020 and 2019, the following pre-tax (gains) or charges were included in net earnings attributable to Altria:

	2020 Quarters
(in millions)	1st		2nd		3rd		4th
Impairment of JUUL equity securities	$	—	$	—	$	2,600	$	—
JUUL changes in fair value	—		—		—		(100)
Tobacco and health litigation items, including accrued interest	24		18		34		7
Asset impairment, exit, implementation and acquisition-related costs	395		8		12		16
ABI-related special items	56		120		513		74
Cronos-related special items	89		(88)		143		(93)
PMCC residual value adjustments	—		34		—		91
COVID-19 special items	—		50		—		—
	$	564	$	142	$	3,302	$	(5)
	2019 Quarters
(in millions)	1st		2nd		3rd		4th
Impairment of JUUL equity securities	$	—	$	—	$	4,500	$	4,100
Tobacco and health litigation items, including accrued interest	17		28		3		29
Asset impairment, exit, implementation and acquisition-related costs	159		45		11		116
ABI-related special items (1)	163		(129)		(23)		(394)
Cronos-related special items	425		119		549		(165)
	$	764	$	63	$	5,040	$	3,686

(1) Prior period amounts have been recast to conform with current period presentation for certain ABI mark-to-market adjustments.